Diabetes. Diabetes mellitus
Conditions
Interventions
Intervention 1: The intervention group consisted of 10 male patients with type2 diabetes. In these group, subjects in addition diet and medicine regime for 45 min session/day, three days/week for six
Rehabilitation
The intervention group consisted of 10 male patients with type2 diabetes. In these group, subjects in addition diet and medicine regime for 45 min session/day, three days/week for six weeks with inten
The control group consisted of 9 male patients with type2 diabetes. In these group, during the study period, no regular exercise just follow their diet and medicine regime.
Sponsors
Research Deputy of Tarbiat Modares University
Endocrinology and Metabolic Research Institute of Tehran University of Medical sciences
Eligibility
Sex/Gender
Male
Age
40 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 40-50 years old; patients with type II diabetes; use of common drugs; duration of diabetes Less than 10 years; HbA1C between 6.5-8; BMI between 20-25. Exclusion criteria: participate in sports activities at least a year before the study; using alcohol, cigarettes…; having a history of heart disease and hypertension; having diabetic foot ulcers, Kidney disease; having autonomic neuropathy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin like growth factor-1. Timepoint: Before and after intervention. Method of measurement: ng/mL using blood sampling.;Insulin like growth factor binding protein-3. Timepoint: Before and after intervention. Method of measurement: ng/mL using blood sampling.;Fasting glucose. Timepoint: Before and after intervention. Method of measurement: mg/dL using blood sampling.;Insulin sensitivity. Timepoint: Before and after intervention. Method of measurement: QUICKI method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: before and after intervention. Method of measurement: mmHg using the mercury manometer.;Cholesterol. Timepoint: before and after intervention. Method of measurement: mg/dL using blood sampling.;Triglycerides. Timepoint: before and after intervention. Method of measurement: mg/dL using blood sampling.;HDL. Timepoint: before and after intervention. Method of measurement: mg/dL using blood sampling.;TNF-a. Timepoint: before and after intervention. Method of measurement: pg/ml using blood sampling. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohammad Reza Mohajeri Tehrani
Endocrinology and Metabolism research institute of tehran university of medical science
Outcome results
None listed